Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Accumulated Expenses (2021 - 2025)

Historic Accumulated Expenses for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $113.8 million.

  • LifeStance Health's Accumulated Expenses rose 171.11% to $113.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.8 million, marking a year-over-year increase of 171.11%. This contributed to the annual value of $117.5 million for FY2024, which is 1462.07% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Accumulated Expenses is $113.8 million, which was up 171.11% from $129.2 million recorded in Q2 2025.
  • LifeStance Health's Accumulated Expenses' 5-year high stood at $129.2 million during Q2 2025, with a 5-year trough of $50.4 million in Q2 2021.
  • Over the past 5 years, LifeStance Health's median Accumulated Expenses value was $83.6 million (recorded in 2023), while the average stood at $88.1 million.
  • In the last 5 years, LifeStance Health's Accumulated Expenses skyrocketed by 5106.23% in 2024 and then plummeted by 50.78% in 2025.
  • Over the past 5 years, LifeStance Health's Accumulated Expenses (Quarter) stood at $60.0 million in 2021, then rose by 26.08% to $75.6 million in 2022, then surged by 35.46% to $102.5 million in 2023, then increased by 14.62% to $117.5 million in 2024, then decreased by 3.14% to $113.8 million in 2025.
  • Its last three reported values are $113.8 million in Q3 2025, $129.2 million for Q2 2025, and $99.9 million during Q1 2025.